AtriCure Insider Regina Groves Trims Stake by 2,452 Shares

Rhea-AI Filing Summary

AtriCure, Inc. (ATRC) Form 4: Director Regina E. Groves sold 2,452 common shares on 08-06-2025 at a weighted-average price of $36.82, a transaction valued at roughly $90 k.

After the sale, Groves directly owns 33,715 shares. No derivative securities were involved and the filing does not cite a Rule 10b5-1 trading plan. There are no disclosures of additional insider transactions, compensation changes, or company events in this filing.

The reported sale reduced her direct position by about 6.8% (from 36,167 to 33,715 shares). While a single Form 4 offers limited context, investors often track insider activity as a sentiment gauge. This transaction is modest relative to AtriCure’s average daily volume and does not, by itself, indicate a change in corporate fundamentals.

Positive

• None.

Negative

• Director sold 2,452 shares worth about $90 k, reducing her direct stake by ~6.8%, which some investors may view as a cautious signal.

Insights

Securities Analyst

TL;DR: Modest insider sale; unlikely to materially impact valuation.

Groves’ ~$90 k disposition represents a small fraction of both her holdings and ATRC’s typical trading volume. The absence of a 10b5-1 reference suggests a discretionary sale, but the stake reduction (≈6.8%) is not large enough to infer strategic shifts. Insider selling can raise caution flags, yet the limited size and lack of accompanying negative disclosures keep the overall signal neutral. Still, investors tracking governance may note that this is the second reported sale in the past few months, warranting continued monitoring of board-level activity.

Insider Trade Summary

Net Seller: 2,452 shares ($90,283)

Net Sell 1 txn

Insider GROVES REGINA E

Role Director

Sold 2,452 shs ($90K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,452	$36.82	$90K

Holdings After Transaction: Common Stock — 33,715 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GROVES REGINA E

(Last) (First) (Middle)

7555 INNOVATION WAY

(Street)

MASON OH 45040-9695

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2025		S		2,452	D	$36.82(1)	33,715	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $36.75 to $36.84 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ Regina E. Groves	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AtriCure (ATRC) shares did Director Regina Groves sell?

She sold 2,452 common shares on 08-06-2025.

At what price were the ATRC shares sold?

The weighted-average sale price was $36.82 per share (trades ranged $36.75-$36.84).

How many ATRC shares does Groves still own after the sale?

She now directly owns 33,715 shares.

Was the sale made under a Rule 10b5-1 trading plan?

The filing does not indicate that the transaction was executed under a 10b5-1 plan.

Were any derivative securities involved in this Form 4?

No, the filing reports no derivative security transactions.

Does this Form 4 mention any other insider transactions?

No additional insider purchases or sales are disclosed in this document.